Efficacy and Safety of Replacing Lenalidomide with Pomalidomide ...

Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing ...

Pomalidomide is possibly a replacement drug for myeloma patients refractory to lenalidomide. Pomalidomide achieves responses among myeloma patients refractory ...

Efficacy and Safety of Pomalidomide As a Replacement Therapy for ...

In this trial, we are evaluating the efficacy, safety and tolerability of POM replacing lenalidomide for pts who were refractory to a ...

Efficacy and safety of pomalidomide as a replacement therapy for ...

Efficacy and safety of pomalidomide as a replacement therapy for lenalidomide for relapsed/refractory multiple myeloma patients refractory to a ...

Efficacy and Safety of Pomalidomide As a Replacement Therapy for ...

We show thatPOM replacement for lenalidomide among RRMM pts who are refractory to a lenalidomide and steroid-containing regimen that includes at ...

Analysis of efficacy and safety of POM as a replacement therapy for ...

Analysis of efficacy and safety of POM as a replacement therapy for lenalidomide for relapsed/refractory multiple myeloma pts refractory to a lenalidomide- ...

Efficacy and safety of pomalidomide, bortezomib, and ... - Nature

Compared to lenalidomide, pomalidomide demonstrates higher potency against cereblon, and has a unique gene activation profile and substrate ...

Efficacy and Safety of Replacing Lenalidomide with Pomalidomide ...

Request PDF | Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing ...

Phase 1 study of pomalidomide MTD, safety, and efficacy in patients ...

Safety and efficacy were evaluated. Thirty-eight patients who had received both bortezomib and lenalidomide (median 6 prior therapies) were enrolled; 63% were ...

Efficacy and safety of replacing lenalidomide with pomalidomide for ...

Efficacy and safety of replacing lenalidomide with pomalidomide for patients with multiple myeloma refractory to a lenalidomide-containing combination regimen.

Efficacy and safety of pomalidomide and low-dose dexamethasone ...

All patients had progressed within 60 days of their last therapy. 74.3% of the patients were resistant to lenalidomide, 31.1% had renal ...

Evaluating the effectiveness and safety of replacing lenalidomide ...

This study evaluated the effectiveness and safety of replacing lenalidomide (Revlimid) with pomalidomide (Pomalyst) for the treatment of patients with ...

Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple ...

Efficacy and safety of replacing lenalidomide with pomalidomide for patients with multiple myeloma refractory to a lenalidomide-containing combination regimen.

Full article: Pomalidomide, dexamethasone, and daratumumab ...

For patients with lenalidomide-refractory disease, these outcomes were 76.2%, 47.6%, and 23.7 months, respectively. No new safety signals were observed; 64.3% ...

Safety and efficacy of pomalidomide plus low-dose dexamethasone ...

Most patients were refractory to lenalidomide and/or bortezomib: 95.9% of patients were refractory to lenalidomide and 4.1% were relapsed; 83.7% ...

Efficacy and Safety of Replacing Lenalidomide with Pomalidomide ...

Efficacy and Safety of Replacing Lenalidomide with Pomalidomide for Patients with Multiple Myeloma Refractory to a Lenalidomide-Containing Combination Regimen.

A Meta-Analysis of the Efficacy of Pomalidomide-Based Regimens ...

Pomalidomide-based combination regimens were effective in patients with RRMM previously treated with lenalidomide and tended to be associated with better ...

Pomalidomide for Lenalidomide for Relapsed or Refractory Multiple ...

This is a phase 2, multicenter, open-label and non-randomized study to evaluate the efficacy and safety of pomalidomide as a replacement for ...

Pomalidomide, bortezomib, and dexamethasone for multiple ...

Significant improvement in overall response rate was also observed with PVd vs Vd in lenalidomide-refractory (85.9% vs 50.8%; P < 0.001) and ...

Efficacy and safety of generic pomalidomide plus low-dose ...

In this open-label, single-arm, multicenter clinical trial, generic pomalidomide demonstrated a similar efficacy and safety profile in Chinese ...